{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:26:26Z","timestamp":1788960386477,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ajp.2020.102457","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T10:51:45Z","timestamp":1603536705000},"page":"102457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Impact of initiating long-acting injectable paliperidone palmitate on relapse and hospitalization in patients with bipolar I disorder: A mirror image retrospective study"],"prefix":"10.1016","volume":"54","author":[{"given":"Ali Metehan","family":"Caliskan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saliha","family":"Calisir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sila","family":"Caliskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikbal","family":"Inanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Eren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2020.102457_bib0005","doi-asserted-by":"crossref","DOI":"10.1586\/ern.10.143","article-title":"Risperidone long-acting injectable (Risperdal Consta\u00ae) for maintenance treatment in patients with bipolar disorder","author":"Bobo","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ajp.2020.102457_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/WNF.0000000000000103","article-title":"Paliperidone palmitate depot in the long-term treatment of psychotic bipolar disorder: A case series","volume":"38","author":"Buoli","year":"2015","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ajp.2020.102457_bib0015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4088\/JCP.16m11201","article-title":"Efficacy and safety of aripiprazole once-monthly in the maintenance treatment of bipolar i disorder: a double-blind, placebo-controlled, 52-week randomized withdrawal study","volume":"78","author":"Calabrese","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2020.102457_bib0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jad.2017.10.035","article-title":"Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder","volume":"227","author":"Calabrese","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ajp.2020.102457_bib0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5498\/wjp.v6.i4.399","article-title":"Treatment-adherence in bipolar disorder: a patient-centred approach","volume":"6","author":"Chakrabarti","year":"2016","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.ajp.2020.102457_bib0030","doi-asserted-by":"crossref","DOI":"10.9758\/cpn.2015.13.2.121","article-title":"A systemic review and experts\u2019 consensus for long-acting injectable antipsychot","author":"Chou","year":"2015","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.ajp.2020.102457_bib0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/TCRM.S81581","article-title":"A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder","volume":"12","author":"Chue","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ajp.2020.102457_bib0040","doi-asserted-by":"crossref","DOI":"10.1515\/hmbci-2017-0004","article-title":"Safety concerns associated with second-generation antipsychotic long-acting injection treatment. A systematic update","author":"Gentile","year":"2018","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.ajp.2020.102457_bib0045","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1176\/ps.2006.57.5.660","article-title":"Pharmacological treatment patterns at study entry for the first 500 STEP-BD participants","volume":"57","author":"Ghaemi","year":"2006","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.ajp.2020.102457_bib0050","doi-asserted-by":"crossref","DOI":"10.2165\/11631310-000000000-00000","article-title":"Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder","author":"Gigante","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajp.2020.102457_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","author":"Grande","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.ajp.2020.102457_bib0060","doi-asserted-by":"crossref","DOI":"10.1007\/s40263-019-00629-z","article-title":"Long-acting injectable Second-Generation\/Atypical antipsychotics for the management of bipolar disorder: a systematic review","author":"Keramatian","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajp.2020.102457_bib0065","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-11-6","article-title":"One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis","volume":"11","author":"Kim","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ajp.2020.102457_bib0070","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jamapsychiatry.2017.4711","article-title":"Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a finnish nationwide cohort of patients with bipolar disorder","volume":"75","author":"L\u00e4hteenvuo","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ajp.2020.102457_bib0075","doi-asserted-by":"crossref","DOI":"10.1034\/j.1600-0447.2002.1r084.x","article-title":"Treatment non-adherence in affective disorders","author":"Lingam","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ajp.2020.102457_bib0080","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-13-340","article-title":"Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness","volume":"13","author":"Llorca","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ajp.2020.102457_bib0085","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1399-5618.2009.00761.x","article-title":"A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently","volume":"11","author":"Macfadden","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2020.102457_bib0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/YIC.0b013e3282f2b4c5","article-title":"Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients","volume":"23","author":"Malempati","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2020.102457_bib0095","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/YIC.0b013e328343ba60","article-title":"Long-term efficacy of risperidone long-acting injectable in bipolar disorder with psychotic features: a prospective study of 3-year outcomes","volume":"26","author":"Malempati","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2020.102457_bib0100","article-title":"Paliperidone LAI and aripiprazole LAI plasma level monitoring in the prophylaxis of bipolar disorder type I with manic predominance","author":"Mauri","year":"2020","journal-title":"Pharmacopsychiatry."},{"key":"10.1016\/j.ajp.2020.102457_bib0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/YIC.0000000000000155","article-title":"The impact of paliperidone palmitate long-acting injection on hospital admissions in a mental health setting","volume":"32","author":"Nikoli\u0107","year":"2017","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2020.102457_bib0110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-5618.2006.00314.x","article-title":"Treatment adherence with antipsychotic medications in bipolar disorder","volume":"8","author":"Sajatovic","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2020.102457_bib0115","doi-asserted-by":"crossref","DOI":"10.3109\/08039488.2013.801078","article-title":"What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?","author":"Samalin","year":"2014","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.ajp.2020.102457_bib0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/15622970701530917","article-title":"A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone","volume":"9","author":"Vieta","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2020.102457_bib0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.euroneuro.2012.03.004","article-title":"A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder","volume":"22","author":"Vieta","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2020.102457_bib0130","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ajp.2020.102457_bib0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jad.2016.03.043","article-title":"Comparative effectiveness of long-acting injectable risperidone vs. Long-acting injectable first-generation antipsychotics in bipolar disorder","volume":"197","author":"Wu","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ajp.2020.102457_bib0140","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2217\/cer-2018-0068","article-title":"Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder","volume":"7","author":"Yan","year":"2018","journal-title":"J. Comp. Eff. Res."},{"key":"10.1016\/j.ajp.2020.102457_bib0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201820305700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201820305700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:42:55Z","timestamp":1761756175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201820305700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":29,"alternative-id":["S1876201820305700"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2020.102457","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of initiating long-acting injectable paliperidone palmitate on relapse and hospitalization in patients with bipolar I disorder: A mirror image retrospective study","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2020.102457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102457"}}